Attached files
| file | filename |
|---|---|
| 10-K - 10-K - HEMAGEN DIAGNOSTICS INC | hem10k09302011.htm |
| EX-23 - EXHIBIT 23 - HEMAGEN DIAGNOSTICS INC | ex23.htm |
| EX-31.2 - EXHIBIT 31.2 - HEMAGEN DIAGNOSTICS INC | ex312.htm |
| EX-32.1 - EXHIBIT 32.1 - HEMAGEN DIAGNOSTICS INC | ex321.htm |
| EX-32.2 - EXHIBIT 32.2 - HEMAGEN DIAGNOSTICS INC | ex322.htm |
| EX-31.1 - EXHIBIT 31.1 - HEMAGEN DIAGNOSTICS INC | ex311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - HEMAGEN DIAGNOSTICS INC | Financial_Report.xls |
Exhibit 10.21
SEVENTH ALLONGE
TO
PROMISSORY NOTE
FROM
HEMAGEN DIAGNOSTICS, INC.
AND
REAGENTS APPLICATIONS, INC.
PAYABLE TO THE ORDER OF TIFUNDING LLC
IN THE ORIGINAL PRINCIPAL AMOUNT OF
$1,000,000
DATED SEPTEMBER 26, 2002
(the “Promissory Note”)
Recital
TiFunding LLC, a Delaware limited liability company, and the holder now desire to make certain revisions to the Promissory Note.
WITH THE CONSENT OF THE MAKER AND HOLDER, the Promissory Note identified in the caption above is hereby amended as follows.
1. Maturity Date. “Maturity Date” shall mean October 1, 2012, subject to acceleration as provided in the Promissory Note.
2. Interpretation. The Promissory Note shall be read, interpreted and construed to give effect to the terms of the Sections above, which shall supersede and control any contradictory or conflicting terms in the original Promissory Note.
3. Effect of Allonge. Except for the change of terms set forth in the Sections above, all other terms and conditions of the Promissory Note shall remain in full force and effect. This Allonge shall not extinguish, terminate, affect, nor impair the Borrower’s obligations under the Promissory Note, and shall not extinguish, terminate, impair or otherwise affect the lien and security interest created under the Loan Documents. All terms used in this Allonge not otherwise defined herein shall have the same meanings ascribed to those terms in the Promissory Note. This Allonge forms an integral part of the Promissory Note to which it is attached and made a part of, and the two shall be read together as one instrument.
[Remainder of page intentionally left blank.]
Executed effective as of the 23rd day of December , 2011.
HEMAGEN DIAGNOSTICS, INC.
By: /s/ Catherine M. Davidson
Name: Catherine M. Davidson
Title: Principal Financial Officer, Controller
TIFUNDING LLC
By: /s/ William P. Hales
Name: William P. Hales
Title: Managing Member
By: /s/ Thomas E. Hales
Name: Thomas E. Hales
Title: Member